Company
JapanTayca Corporation, Okayama, Japan – FDA Inspections
Inspection records and compliance data for Tayca Corporation in Okayama. 5 FDA inspections on record, 2 Form 483s, last inspected August 25, 2023.
Company Profile
This profile covers Tayca Corporation based in Okayama, Japan.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 4
- NAI
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected August 27, 2009. Last inspected August 25, 2023.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 25, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1219130 |
| December 15, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1038594 |
| September 9, 2016 | VAI | Human Drugs · Drug Quality Assurance | 989845 |
| November 8, 2013 | VAI | Human Drugs · Drug Quality Assurance | 855688 |
| August 27, 2009 | NAI | Human Drugs · Drug Quality Assurance | 615187 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Cdymax (India) Pharma Private Limited
Hetero Drugs Ltd. - Unit 1
Hetero Labs Limited
Corden Pharma Colorado, Inc.
International Chemical Entity Japan Co., Ltd.
Linhai Tianyu Pharmaceutical Co., Ltd.
Zhuhai Rundu Pharmaceutical Co Ltd
Shandong Luxi Pharmaceutical Co., Ltd.
Goodwin Biotechnology, Inc.
Ajinomoto Health & Nutrition North America, Inc.
Company Information
Name
Tayca Corporation
FEI Number
3002777902
Address
1072 Nishikozai, Higashi; Nishikozai; Higashi; Nishikozai; Higashi, Okayama, Japan
Country
Japan
ID: 46216ddd-c2d8-492b-bbc2-7011e93a98bf